Tania Flores

Tania Flores

Auto-generated profile, based on publicly available information

Tania Flores

Institute for Research in Dental Sciences, Faculty of Dentistry Universidad de Chile Santiago Chile

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
RFRamón Fuentes
Ramón Fuentes
TFTania Flores
Tania Flores
PNPablo Navarro
Pablo Navarro
CSCarlos Salamanca
Carlos Salamanca
VBVíctor Beltrán
Víctor Beltrán
Eduardo BorieEduardo Borie
Eduardo Borie
The aim of this study was to analyze the anatomical dimensions of the buccal bone walls of the aesthetic maxillary region for immediate implant placement, based upon cone-beam computed tomography (CBCT) scans in a sample of adult patients. Two calibrated examiners analyzed a sample of 50 CBCT scans, performing morphometric analyses of both incisors and canines on the left and right sides. Subsequently, in the sagittal view, a line was traced through the major axis of the selected tooth. Then, a second line (E) was traced from the buccal to the palatal wall at the level of the observed bone ridges. The heights of the buccal and palatal bone ridges were determined at the major axis of the tooth. The buccal bone thickness was measured across five lines. The first was at the level of line E. The second was at the most apical point of the tooth, and the other three lines were equidistant between the apical and the cervical lines, and parallel to them. Statistical analysis was performed with a significance level of P≤0.05 for the bone thickness means and standard deviations per tooth and patient for the five lines at varying depths. The means of the buccal wall thicknesses in the central incisors, lateral incisors and canines were 1.14±0.65 mm, 0.95±0.67 mm and 1.15±0.68 mm, respectively. Additionally, only on the left side were significant differences in some measurements of buccal bone thickness observed according to age and gender. However, age and gender did not show significant differences in heights between the palatal and buccal plates. In a few cases, the buccal wall had a greater height than the palatal wall. Less than 10% of sites showed more than a 2-mm thickness of the buccal bone wall, with the exception of the central incisor region, wherein 14.4% of cases were ≥2 mm.

9 October 2023 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
DPDaniel Peña-Oyarzún
Daniel Peña-Oyarzún
TFTania Flores
Tania Flores
VTVicente Torres
Vicente Torres
AQAndrew FG Quest
Andrew FG Quest
lorena Lobos-Gonzalezlorena Lobos-Gonzalez
lorena Lobos-Gonzalez
POPamela Orellana
Pamela Orellana
Purpose: Oral squamous cell carcinoma (OSCC) is commonly preceded by potentially malignant lesions, referred to as oral dysplasia. We recently reported that oral dysplasia is associated with aberrant activation of the Wnt/β-catenin pathway, due to overexpression of Wnt ligands in a Porcupine (PORCN)-dependent manner. Pharmacologic inhibition of PORCN precludes Wnt secretion and has been proposed as a potential therapeutic approach to treat established cancers. Nevertheless, there are no studies that explore the effects of PORCN inhibition at the different stages of oral carcinogenesis. Experimental Design: We performed a model of tobacco-induced oral cancer in vitro, where dysplastic oral keratinocytes (DOK) were transformed into oral carcinoma cells (DOK-TC), and assessed the effects of inhibiting PORCN with the C59 inhibitor. Similarly, an in vivo model of oral carcinogenesis and ex vivo samples derived from patients diagnosed with oral dysplasia and OSCC were treated with C59. Results: Both in vitro and ex vivo oral carcinogenesis approaches revealed decreased levels of nuclear β-catenin and Wnt3a, as observed by immunofluorescence and IHC analyses. Consistently, reduced protein and mRNA levels of survivin were observed after treatment with C59. Functionally, treatment with C59 in vitro resulted in diminished cell migration, viability, and invasion. Finally, by using an in vivo model of oral carcinogenesis, we found that treatment with C59 prevented the development of OSCC by reducing the size and number of oral tumor lesions. Conclusions: The inhibition of Wnt ligand secretion with C59 represents a feasible treatment to prevent the progression of early oral lesions toward OSCC.


5 January 2024
Verified
Other
Open access
PDF file
DPDaniel Peña-Oyarzún
Daniel Peña-Oyarzún
TFTania Flores
Tania Flores
VTVicente Torres
Vicente Torres
AQAndrew FG Quest
Andrew FG Quest
lorena Lobos-Gonzalezlorena Lobos-Gonzalez
lorena Lobos-Gonzalez
MRMontserrat Reyes
Montserrat Reyes
Characterization of the in vitro human oral carcinogenesis model


5 January 2024
Verified
Other
Open access
DPDaniel Peña-Oyarzún
Daniel Peña-Oyarzún
TFTania Flores
Tania Flores
VTVicente Torres
Vicente Torres
AQAndrew FG Quest
Andrew FG Quest
lorena Lobos-Gonzalezlorena Lobos-Gonzalez
lorena Lobos-Gonzalez
MRMontserrat Reyes
Montserrat Reyes
Purpose:Oral squamous cell carcinoma (OSCC) is commonly preceded by potentially malignant lesions, referred to as oral dysplasia. We recently reported that oral dysplasia is associated with aberrant activation of the Wnt/β-catenin pathway, due to overexpression of Wnt ligands in a Porcupine (PORCN)-dependent manner. Pharmacologic inhibition of PORCN precludes Wnt secretion and has been proposed as a potential therapeutic approach to treat established cancers. Nevertheless, there are no studies that explore the effects of PORCN inhibition at the different stages of oral carcinogenesis.Experimental Design:We performed a model of tobacco-induced oral cancer in vitro, where dysplastic oral keratinocytes (DOK) were transformed into oral carcinoma cells (DOK-TC), and assessed the effects of inhibiting PORCN with the C59 inhibitor. Similarly, an in vivo model of oral carcinogenesis and ex vivo samples derived from patients diagnosed with oral dysplasia and OSCC were treated with C59.Results:Both in vitro and ex vivo oral carcinogenesis approaches revealed decreased levels of nuclear β-catenin and Wnt3a, as observed by immunofluorescence and IHC analyses. Consistently, reduced protein and mRNA levels of survivin were observed after treatment with C59. Functionally, treatment with C59 in vitro resulted in diminished cell migration, viability, and invasion. Finally, by using an in vivo model of oral carcinogenesis, we found that treatment with C59 prevented the development of OSCC by reducing the size and number of oral tumor lesions.Conclusions:The inhibition of Wnt ligand secretion with C59 represents a feasible treatment to prevent the progression of early oral lesions toward OSCC.